Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126257981 | 12625798 | 1 | I | 20160725 | 20160805 | 20160805 | EXP | BR-NOVOPROD-503187 | NOVO NORDISK | 43.00 | YR | A | M | Y | 137.00000 | KG | 20160805 | MD | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126257981 | 12625798 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Unknown | 0.6 MG, QD | U | U | UNKNOWN | 22341 | .6 | MG | SOLUTION FOR INJECTION | QD | |||
126257981 | 12625798 | 2 | SS | VICTOZA | LIRAGLUTIDE | 1 | Unknown | 3.0 MG, QD | U | U | UNKNOWN | 22341 | 3 | MG | SOLUTION FOR INJECTION | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126257981 | 12625798 | 1 | Obesity |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126257981 | 12625798 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126257981 | 12625798 | Cholelithiasis | |
126257981 | 12625798 | Nausea | |
126257981 | 12625798 | Off label use | |
126257981 | 12625798 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |